Ivars Rubio A, Yufera JC, de la Morena P, Fernández Sánchez A, Navarro Manzano E, García Garre E, García Martinez E, Marín Zafra G, Sánchez Cánovas M, García Torralba E, Ayala de la Peña F. Neutrophil-lymphocyte ratio in metastatic breast cancer is not an independent predictor of survival, but depends on other variables. Sci Rep. 2019 Nov 18;9(1):16979. doi: 10.1038/s41598-019-53606-3. PubMed PMID: 31740715; PubMed Central PMCID: PMC6861311.
AÑO: 2019; IF: 3.998
|
Bravo-Perez C, García-Torralba E, Lopez-Poveda MJ, Ortuño FJ. CD56- and CD117-positive neuroendocrine neoplasm presenting with leukemic phase and bone marrow infiltration mimicking acute leukemia. Int J Lab Hematol. 2021 Aug;43(4):536-537. doi: 10.1111/ijlh.13578. Epub 2021 Jun 4. PubMed PMID: 34086417.
AÑO: 2021; IF: 3.45
|
Bravo-Perez C, Fernández-Caballero M, Soler-Espejo E, Garcia-Torralba E, Sorigue M, García-Malo MD, Jerez A, Vicente V, Roldán V, de Arriba F. Heparin versus aspirin thromboprophylaxis adds independent value to IMPEDE-VTE score for venous thrombosis prediction in multiple myeloma. J Thromb Thrombolysis. 2021 Oct;52(3):848-853. doi: 10.1007/s11239-021-02407-5. Epub 2021 Mar 1. PubMed PMID: 33649980.
AÑO: 2021; IF: 5.221
|
Garcia-Torralba E, Navarro Manzano E, Luengo-Gil G, De la Morena Barrio P, Chaves Benito A, Perez-Ramos M, Alvarez-Abril B, Ivars Rubio A, Garcia-Garre E, Ayala de la Pena F, Garcia-Martinez E. A new prognostic model including immune biomarkers, genomic proliferation tumor markers (AURKA and MYBL2) and clinical-pathological features optimizes prognosis in neoadjuvant breast cancer patients. Front Oncol. 2023 May 29;13:1182725. doi: 10.3389/fonc.2023.1182725. eCollection 2023. PubMed PMID: 37313470; PubMed Central PMCID: PMC10258327.
AÑO: 2023; IF: 4.7
|
Pabellón Docente del Hospital
Clínico Universitario Virgen de la Arrixaca - 3ª Planta
C/ Campo 12, 30120 - El Palmar - Murcia, España
+34 968359767
+34 968381298